Cited by 66Seaweed-derived Bioactive CompoundsBlood Pressure and Hypertension StudiesSodium Intake and Health

Clinical Effects of Brown Seaweed, Undaria pinnatifida (wakame), on Blood Pressure in Hypertensive Subjects.

Open access
HATA, Yoshiya, NAKAJIMA, Kumiko, UCHIDA, Jun-ichi, HIDAKA, Hidemasa, NAKANO, Takahisa·2001·Journal of Clinical Biochemistry and Nutrition

Abstract

This was conducted to examine the effects of brown seaweed (wakame) on blood pressure and serum biochemical parameters in hypertensive subjects. Of the 37 elderly out-patients with hypertension who started the study, 36 of them completed it. This study was a randomly assigned, case-controlled one. Nineteen patients received a daily dose of 5g of dried wakame powder packed in 12 capsules. Eighteen gender-matched subjects with age difference±2 years, and starting time of participation within±2 weeks, were selected as the control group. Patients visited the clinic every 4 weeks. The observation period was 8 weeks. In the wakame group, the average amount of wakame ingested was 3.3g. The systolic blood pressure (SBP) in this group dropped 13mmHg below the baseline (p<0.01) after 4 weeks, and 8mmHg (p<0.05) after 8 weeks. The diastolic blood pressure (DBP) decreased by 9mmHg (p<0.01) after 4 weeks and by 8mmHg (p<0.05) after 8 weeks. In the control group, no significant changes were seen in either SBP or DBP. However, the differences in reduction in SBP and DBP were significant between the wakame and control groups. Regarding clinical chemistry data, hypercholesterolemia in the wakame group decreased by 8% after 4 weeks. No other abnormal changes were observed in either group. We conclude that wakame has beneficial effects as a supplemental regimen in the treatment of hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3164/jcbn.30.43

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 35 · Cited by 66

Research works printed but not linked: 4

  1. Japan Hypertension Society Working Group (Kaneko, Y. et al., 1994): Guideline for clinical evaluation of drugs in research and development, in Handbook of Guidelines for Development of New Drugs, Yakugyo Jiho, Tokyo, pp. 222-239.
  2. Mitsuoka, T. (1994): Current status and future prospects of studies on intestinal flora and dietary factors, in Intestinal Flora and Dietary Factors, ed. by Mitsuoka, T., Gakkai Shuppan Center, Tokyo, pp. 1-14.
  3. Story, J.A., Kritchevsky, D., and Eastwood, M.A. (1979): Dietary fibre-bile acid interactions, in Dietary Fiber-Chemistry and Nutrition, ed. by Inglett, G.E., and Falkenag, S.I., Aca- demic Press, New York, pp. 49-55.
  4. Harlan, W.R., and Harlan, L.C. (1995): Blood pressure and calcium and magnecium intake, in Hypertension-Pathophysiology, Diagnosis and Management, 2nd ed., ed. by Laragh, J.H., and Briwn, B.M., Raven Press, New York, pp. 1143-1154.

Authors
HATA, Y., NAKAJIMA, K., UCHIDA, J.-I., HIDAKA, H., & NAKANO, T.
Affiliations
  • Kyorin University (JP)
  • Tokiwa University (JP)
  • Riken Vitamin Co., Ltd. (Japan) (JP)
Venue
Journal of Clinical Biochemistry and Nutrition
Published
2001
Volume
30
Pages
43-53
ISSN
  • 0912-0009 (ISSN-L)
  • 1880-5086
OpenAlex
W2070237122
Cited by
66
References
35
Citations by year
2026: 7 · 2025: 2 · 2024: 3 · 2023: 12 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 4 · 2013: 1
FWCI
1.40
Type
journal article
Language
en
Open access
Locations
Journal of Clinical Biochemistry and Nutrition (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
Undaria pinnatifida, brown algae, hypertension, blood pressure reduction, systolic blood pressure, diastolic blood pressure, hypercholesterolemia, serum cholesterol, dietary supplementation, elderly patients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review